Clinicians will soon face challenging decisions on which immunotherapies to prescribe their patients, and in what sequence or combination.
Kate Venmar
Advertisement
Articles by Kate Venmar
Several novel approaches to the delivery of therapeutics for advanced melanoma may improve treatment efficacy and patient survival.
Advertisement
Latest Updated Articles
Melanoma Drug Delivery Approaches AdvancingPublished: November 19th 2014 | Updated:
Programs Prepare for Immuno-Oncology in Clinical SettingPublished: November 26th 2014 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
